Callum Meikle
Direttore/Membro del Consiglio presso Scottish Ballet
Profilo
Callum Meikle has worked as a Director at Scottish Ballet and as a Non-Executive Director at Pleco Therapeutics BV.
Posizioni attive di Callum Meikle
| Società | Posizione | Inizio |
|---|---|---|
Scottish Ballet
 Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Direttore/Membro del Consiglio | - |
Pleco Therapeutics BV
 Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Scottish Ballet
Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Consumer Services |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Commercial Services |
- Borsa valori
- Insiders
- Callum Meikle
